Therapy of Chronic Cold Agglutinin Disease With Eculizumab

NCT01303952 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cold Agglutinin Disease

Interventions

DRUG: Eculizumab

Sponsor

University Hospital, Essen

Collaborators

[object Object]